(Q43935449)

English

A tailored therapy for the metabolic syndrome: the dual peroxisome proliferator-activated receptor-alpha/gamma agonist LY465608 ameliorates insulin resistance and diabetic hyperglycemia while improving cardiovascular risk factors in preclinical mode

scientific article published in April 2002

Statements

A tailored therapy for the metabolic syndrome: the dual peroxisome proliferator-activated receptor-alpha/gamma agonist LY465608 ameliorates insulin resistance and diabetic hyperglycemia while improving cardiovascular risk factors in preclinical mode (English)
Garret J Etgen
Brian A Oldham
William T Johnson
Carol L Broderick
Chahrzad R Montrose
Joseph T Brozinick
Elizabeth A Misener
James S Bean
William R Bensch
Dawn A Brooks
Anthony J Shuker
Christopher J Rito
James R McCarthy
Robert J Ardecky
John S Tyhonas
Sharon L Dana
James M Bilakovics
James R Paterniti
Kathleen M Ogilvie
Sha Liu
Raymond F Kauffman
1 April 2002
1083-1087

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit